Advancing Biosimilar Sustainability in Europe (2018)

A growing number of biologic medicines have been developed and approved over the past decade, improving the lives of patients worldwide. Although these have been effective at treating numerous diseases, patient access has been limited, partly due to their relatively high cost.

ORGANIZATION:

RESOURCE TYPE:
REPORT